7/3/25 16:11 | 7/1/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 1 | S | -10 | 9.82 | 0 | -1 | | 95 | D | | | | | | | | | | | | | | |
7/3/25 16:07 | 7/2/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -25 | 9.95 | 0 | -3 | | 57 | D | | | | | | | | | | | | | | |
7/2/25 17:50 | 6/30/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goodman Jesse | MA | D | | 1 | S.m | -29 | 9.40 | 0 | -3 | | 24 | D | | | | | | | | | | | | | | |
7/1/25 16:59 | 6/27/25 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Demski Martha J | CA | D | | 1 | S | -41 | 5.06 | 0 | -8 | | 12 | D | | | | | | | | | | | | | | |
6/17/25 16:31 | 6/13/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | 2 | S | -950 | 79.20 | 0 | -12 | | 93 | D | | | | | | | | | | | | | | |
6/11/25 16:33 | 6/9/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McHugh Julie | MA | D | | 1 | S | -424 | 81.62 | 0 | -5 | | 26 | D | | | | | | | | | | | | | | |
6/11/25 16:32 | 6/9/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | 1 | S.d | -3,301 | 83.00 | 0 | -40 | | 89 | D | | | | | | | | | | | | | | |
6/9/25 16:34 | 6/5/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | 1 | S | -526 | 79.65 | 0 | -7 | | 112 | D | | | | | | | | | | | | | | |
6/4/25 16:32 | 6/2/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | 1 | S | -2,003 | 76.83 | 0 | -26 | | 585 | D | | | | | | | | | | | | | | |
5/14/25 17:00 | 5/13/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | 1 | S.d | -1,359 | 506.41 | 0 | -3 | | 3 | D | | | | | | | | | | | | | | |
5/13/25 17:00 | 5/9/25 | IDXX | Idexx Laboratories Inc /De | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | 1 | S.d | -628 | 491.34 | 0 | -1 | | 9 | D | | | | | | | | | | | | | | |
5/1/25 16:24 | 4/29/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | 1 | S | -2 | 8.50 | 0 | 0 | | 19 | D | | | | | | | | | | | | | | |